Episode 82
Biotech Hangout
00:00
Introduction
Discussion on the performance of the biotech market in 2023, focusing on regulatory decisions, clinical readouts, financial updates, and announced BD events. Highlighting the lack of significant trading before big BD events and the bigger pop in stock performance for companies with positive surprises in revenue.
Play episode from 00:00
Transcript
